BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 36814584)

  • 1. Prognostic significance of the triglyceride-glucose index for patients with ischemic heart failure after percutaneous coronary intervention.
    Sun T; Huang X; Zhang B; Ma M; Chen Z; Zhao Z; Zhou Y
    Front Endocrinol (Lausanne); 2023; 14():1100399. PubMed ID: 36814584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impacts of systemic inflammation response index on the prognosis of patients with ischemic heart failure after percutaneous coronary intervention.
    Ma M; Wu K; Sun T; Huang X; Zhang B; Chen Z; Zhao Z; Zhao J; Zhou Y
    Front Immunol; 2024; 15():1324890. PubMed ID: 38440729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic impacts of geriatric nutritional risk index in patients with ischemic heart failure after percutaneous coronary intervention.
    Sun T; Ma M; Huang X; Zhang B; Chen Z; Zhao Z; Zhou Y
    Clin Nutr; 2023 Aug; 42(8):1260-1267. PubMed ID: 37343410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of triglyceride-glucose index in patients with chronic coronary syndrome undergoing percutaneous coronary intervention.
    Tao S; Yu L; Li J; Xie Z; Huang L; Yang D; Tan Y; Zhang W; Huang X; Xue T
    Cardiovasc Diabetol; 2023 Nov; 22(1):322. PubMed ID: 38017540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triglyceride-glucose index is associated with poor prognosis in acute coronary syndrome patients with prior coronary artery bypass grafting undergoing percutaneous coronary intervention.
    Dong S; Zhao Z; Huang X; Ma M; Yang Z; Fan C; Han H; Wang Z; Shi D; Zhou Y
    Cardiovasc Diabetol; 2023 Oct; 22(1):286. PubMed ID: 37891647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A synergistic effect of the triglyceride-glucose index and the residual SYNTAX score on the prediction of intermediate-term major adverse cardiac events in patients with type 2 diabetes mellitus undergoing percutaneous coronary intervention.
    Xiong S; Chen Q; Zhang Z; Chen Y; Hou J; Cui C; Cheng L; Su H; Long Y; Yang S; Qi L; Chen X; Liu H; Cai L
    Cardiovasc Diabetol; 2022 Jun; 21(1):115. PubMed ID: 35751060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjustment of the GRACE score by the triglyceride glucose index improves the prediction of clinical outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
    Xiong S; Chen Q; Chen X; Hou J; Chen Y; Long Y; Yang S; Qi L; Su H; Huang W; Liu H; Zhang Z; Cai L
    Cardiovasc Diabetol; 2022 Aug; 21(1):145. PubMed ID: 35932019
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High triglyceride-glucose index is associated with poor cardiovascular outcomes in Chinese acute coronary syndrome patients without diabetes mellitus who underwent emergency percutaneous coronary intervention with drug-eluting stents.
    Zhang Y; Chu C; Zhong Z; Luo YB; Ning FF; Guo N
    Front Endocrinol (Lausanne); 2023; 14():1101952. PubMed ID: 36875470
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The triglyceride-glucose index predicts 1-year major adverse cardiovascular events in end-stage renal disease patients with coronary artery disease.
    Xie E; Ye Z; Wu Y; Zhao X; Li Y; Shen N; Gao Y; Zheng J
    Cardiovasc Diabetol; 2023 Oct; 22(1):292. PubMed ID: 37891651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Triglyceride-glucose body mass index predicts prognosis in patients with ST-elevation myocardial infarction.
    Liu M; Pan J; Meng K; Wang Y; Sun X; Ma L; Yu X
    Sci Rep; 2024 Jan; 14(1):976. PubMed ID: 38200157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Prognostic Value of the Triglyceride-Glucose Index in Forecasting Ten-Year Major Adverse Cardiovascular Events in Non-Diabetic Patients with Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention.
    Köktürk U; Onalan O; Somuncu MU; Uygur B; Erbay İ; Çakan F; Avcı A
    Turk Kardiyol Dern Ars; 2024 Jun; 52(4):253-259. PubMed ID: 38829642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of dapagliflozin on the prognosis of patients with acute myocardial infarction undergoing percutaneous coronary intervention.
    Zhu Y; Zhang JL; Yan XJ; Sun L; Ji Y; Wang FF
    Cardiovasc Diabetol; 2022 Sep; 21(1):186. PubMed ID: 36114538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triglyceride-glucose index for predicting repeat revascularization and in-stent restenosis in patients with chronic coronary syndrome undergoing percutaneous coronary intervention.
    Guo X; Shen R; Yan S; Su Y; Ma L
    Cardiovasc Diabetol; 2023 Mar; 22(1):43. PubMed ID: 36864455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impacts of triglyceride-glucose index on prognosis of patients with type 2 diabetes mellitus and non-ST-segment elevation acute coronary syndrome: results from an observational cohort study in China.
    Zhao Q; Zhang TY; Cheng YJ; Ma Y; Xu YK; Yang JQ; Zhou YJ
    Cardiovasc Diabetol; 2020 Jul; 19(1):108. PubMed ID: 32641127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The predictive value of the triglyceride-glucose index for cardiovascular events in patients with coronary chronic total occlusion.
    Li Y; He S; Wu Z; Li W; Jian W; Cheng Z; Wang C; Shi Y; Liu J
    Cardiovasc Diabetol; 2022 Aug; 21(1):149. PubMed ID: 35941586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triglyceride glucose index for predicting cardiovascular outcomes after percutaneous coronary intervention in patients with type 2 diabetes mellitus and acute coronary syndrome.
    Ma X; Dong L; Shao Q; Cheng Y; Lv S; Sun Y; Shen H; Wang Z; Zhou Y; Liu X
    Cardiovasc Diabetol; 2020 Mar; 19(1):31. PubMed ID: 32156279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triglyceride-glucose index in the prediction of adverse cardiovascular events in patients with premature coronary artery disease: a retrospective cohort study.
    Wu Z; Liu L; Wang W; Cui H; Zhang Y; Xu J; Zhang W; Zheng T; Yang J
    Cardiovasc Diabetol; 2022 Jul; 21(1):142. PubMed ID: 35906587
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Impact of the Triglyceride-Glucose Index on Poor Prognosis in NonDiabetic Patients Undergoing Percutaneous Coronary Intervention.
    Yang J; Tang YD; Zheng Y; Li C; Zhou Q; Gao J; Meng X; Zhang K; Wang W; Shao C
    Front Endocrinol (Lausanne); 2021; 12():710240. PubMed ID: 34489866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discordance between the triglyceride glucose index and fasting plasma glucose or HbA1C in patients with acute coronary syndrome undergoing percutaneous coronary intervention predicts cardiovascular events: a cohort study from China.
    Hu C; Zhang J; Liu J; Liu Y; Gao A; Zhu Y; Zhao Y
    Cardiovasc Diabetol; 2020 Jul; 19(1):116. PubMed ID: 32703284
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triglyceride-glucose index's link to cardiovascular outcomes post-percutaneous coronary intervention in China: a meta-analysis.
    Sun C; Hu L; Li X; Zhang X; Chen J; Li D; Zhang J; Liu L; Wu M
    ESC Heart Fail; 2024 Jun; 11(3):1317-1328. PubMed ID: 38246749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.